Trump's pledge to unleash American oil and gas benefits certain stocks, impacting EyePoint Pharmaceuticals.
3 reports, 1 independent
Updated Aug 9
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Trump's pledge to unleash American oil and gas benefits certain stocks, impacting EyePoint Pharmaceuticals.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Trump's pledge to unleash oil and gas benefits stocks, specifically involving EyePoint Pharmaceuticals.1 source
Analog Devices is cited as a stock benefiting from Trump's oil and gas pledge.1 source
Keep exploring
The entities involved
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
-
EyePoint Pharmaceuticals (United Kingdom)
company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery
-
Analog Devices
American company
Related events
- Trump's pledge to unleash oil and gas benefits stocks, specifically impacting Mirum Pharmaceuticals.
- Trump's pledge to unleash oil and gas is reported to benefit stocks, involving Stantec.
- Trump's pledge benefits US oil and gas stocks, leading to scrutiny regarding the financial viability of both companies.
- Trump's pledge to unleash oil and gas is reported to benefit stocks, involving Amedisys, Inc.
- Trump's pledge to unleash oil and gas is reported to benefit US stocks, involving G. Willi-Food International.
Coverage
Newest first; wire copies grouped- Simply Wall St.Analysts Have Lowered Expectations For EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) After Its Latest Results Explore EyePoint Pharmaceuticals's Fair Values from the Community and select yours It's sh
- Simply Wall St.At US$222, Is Analog Devices, Inc. (NASDAQ:ADI) Worth Looking At Closely? Analog Devices, Inc. (NASDAQ:ADI) saw a double-digit share price rise of over 10% in the past couple of months on the NASDAQG
- Simply Wall St.Estimating The Fair Value Of Analog Devices, Inc. (NASDAQ:ADI) Analog Devices' estimated fair value is US$255 based on 2 Stage Free Cash Flow to Equity Current share price of US$228 suggests Analog D